mirtazapine 30 mg
1 INDICATIONS AND USAGE Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. (1)
sun pharmaceutical industries, inc.
Related Pills
Mirtazapine 45 MG Oral Tablet
Sun Pharmaceutical Industries, Inc.
mirtazapine tablet
sun pharmaceutical industries, inc.
capecitabine 500 mg
Aurobindo Pharma Limited
valacyclovir tablet film coated
zydus pharmaceuticals (usa) inc.
ac fast paracetamol capsule coated
grimann sa de cv
24 HR Levetiracetam 500 MG Extended Release Oral Tablet
Quinn Pharmaceuticals, LLC
amoxicillin as amoxicillin trihydrate 500 MG clavulanic acid as clavulanate potassium 125 MG Oral Tablet
Preferred Pharmaceuticals, Inc
ciprofloxacin as ciprofloxacin hydrochloride 500 MG Oral Tablet
Pack Pharmaceuticals, LLC
cephalexin as cephalexin monohydrate 500 MG Oral Capsule
Aurobindo Pharma Limited
Naproxen 500 MG Oral Tablet
Glenmark Generics Inc., USA
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
MIRTAZAPINE tablets, USP are supplied as: Tablet Strength Tablet Color/Shape Tablet Markings Package Configuration NDC Code 7.5 mg yellow, circular, biconvex tablet film coated tablets with “C” debossed on one side and plain on the other side Bottle / 30 count NDC 57664-510-83 15 mg yellow, oval, biconvex tablet film coated tablets with “499” debossed on one side and scored on the other side Bottle / 30 count NDC 57664-499-83 Bottle / 1000 count NDC 57664-499-18 30 mg Reddish-brown, oval, biconvex tablet film coated tablets with “500” debossed on one side and scored on the other side Bottle / 30 count NDC 57664-500-83 Bottle / 1000 count NDC 57664-500-18 45 mg white to off-white, oval, biconvex tablet film coated tablets with “501” debossed on one side and plain on the other side Bottle / 30 count NDC 57664-501-83 Bottle / 1000 count NDC 57664-501-18 Storage Store at 20° to 25°C (68° to 77°F); excursions permitted 15° to 30°C (59° to 86°F). [see USP Controlled Room Temperature]. Protect from light and moisture.
More pills like OVAL 500